Medicare Enrolled
Dr. Sridevi Juvvadi, MD
Hematology & Oncology · Irving, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Juvvadi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Juvvadi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Juvvadi
Dr. Sridevi Juvvadi is a hematology & oncology specialist in Irving, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Juvvadi performed 31,137 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Juvvadi received a total of $2,200 from 27 pharmaceutical and/or device companies across 53 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Juvvadi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 28% volume in TX
$2,200 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗31,137
Medicare services
Top 28% in TX for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
11,220 | $0 | $5 |
| Paclitaxel chemotherapy injection | 7,492 | $0 | $8 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,172 | $0 | $1 |
| Denosumab injection (Prolia/Xgeva) | 1,800 | $19 | $66 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,081 | $8 | $20 |
| Injection, granisetron hydrochloride, 100 mcg | 1,060 | $0 | $24 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,044 | $8 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,027 | $10 | $64 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
769 | $65 | $250 |
| Anti-nausea injection (Aloxi/palonosetron) | 440 | $1 | $114 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
298 | $23 | $157 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
285 | $104 | $707 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
194 | $13 | $60 |
| Iron level test | 192 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
192 | $9 | $35 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
138 | $7 | $431 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 125 | $20 | $128 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
125 | $11 | $96 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
109 | $6 | $31 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
108 | $1 | $7 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
104 | $50 | $313 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
96 | $23 | $161 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
88 | $51 | $344 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
84 | $9 | $56 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
78 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
78 | $6 | $34 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
72 | $37 | $150 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
68 | $12 | $108 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
64 | $17 | $60 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
64 | $1 | $19 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
61 | $1 | $8 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 55 | $133 | $3,675 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
51 | $16 | $100 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
49 | $35 | $143 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
44 | $42 | $143 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
38 | $2 | $19 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
31 | $25 | $145 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
30 | $97 | $368 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
29 | $26 | $256 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $132 | $565 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
23 | $10 | $75 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
16 | $1,187 | $4,802 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 16 | $91 | $657 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
39.1% high complexity
43.5% medium
17.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,200
Total received (2018-2024)
Avg $367/year across 6 years
Bottom 41% in TX for hematology & oncology
27
Companies
53
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,328
2023
$178
2022
$281
2021
$205
2019
$153
2018
$55
Payments by company (2024)
Novartis Pharmaceuticals Corporation
$1,085
Apellis Pharmaceuticals, Inc.
$45
Regeneron Healthcare Solutions, Inc.
$34
Merck Sharp & Dohme LLC
$33
Kite Pharma, Inc.
$31
Aveo Pharmaceuticals, Inc.
$26
Geron Corporation
$24
Janssen Biotech, Inc.
$17
PFIZER INC.
$17
E.R. Squibb & Sons, L.L.C.
$15
Top 3 companies account for 87.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,123
Incyte Corporation
$172
Myriad Genetic Laboratories, Inc.
$122
Eisai Inc.
$72
Apellis Pharmaceuticals, Inc.
$68
Regeneron Healthcare Solutions, Inc.
$65
PFIZER INC.
$65
Gilead Sciences, Inc.
$53
Daiichi Sankyo Inc.
$45
GE HealthCare
$44
AstraZeneca Pharmaceuticals LP
$36
Merck Sharp & Dohme LLC
$33
E.R. Squibb & Sons, L.L.C.
$32
Kite Pharma, Inc.
$31
Pharmacosmos Therapeutics Inc.
$27
Aveo Pharmaceuticals, Inc.
$26
Myovant Sciences Inc.
$26
EMD Serono, Inc.
$25
Geron Corporation
$24
EISAI INC.
$23
Janssen Biotech, Inc.
$17
Merck Sharp & Dohme Corporation
$16
Amgen Inc.
$15
Astellas Pharma US Inc
$12
Bayer HealthCare Pharmaceuticals Inc.
$12
Celgene Corporation
$11
Sirtex Medical Inc
$6
Top 3 companies account for 64.4% of all-time payments
Associated products mentioned in payments ›
BOSULIF · ELIQUIS · ENHERTU · Empaveli · EndoPredict · Enhertu · FOTIVDA · KEYTRUDA · KISQALI · LIBTAYO · Lenvima · MONOFERRIC · Nplate · OPDIVO · ORGOVYX · PLUVICTO · RYBREVANT · RYTELO · Revlimid · SIR-Spheres Microspheres · TABRECTA · Trodelvy · XALKORI · XOSPATA · Xofigo · Yescarta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
154
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT & WHITE MEDICAL CENTER AT IRVING
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Juvvadi is a mixed practice specialist, with above-average Medicare volume (top 28% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Juvvadi experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Juvvadi performed 11,220 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Juvvadi receive payments from pharmaceutical companies?
Yes. Dr. Juvvadi received a total of $2,200 from 27 companies across 53 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Juvvadi's costs compare to other hematology & oncology specialists in Irving?
Dr. Juvvadi's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Juvvadi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Irving
Browse hematology & oncology specialists in Irving ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology